Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Theralase Technologies Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Theralase Technologies Inc. market cap is $51.41M.
What is the 52-week high for Theralase Technologies Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Theralase Technologies Inc. 52 week high is $0.27 as of October 10, 2025.
What is the 52-week low for Theralase Technologies Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Theralase Technologies Inc. 52 week low is $0.1157 as of October 10, 2025.
What is Theralase Technologies Inc. stock price today?
Theralase Technologies Inc. stock price today is $0.1403.
What was Theralase Technologies Inc. stock price yesterday?
Theralase Technologies Inc. stock price yesterday was $0.143.
What is the PE ratio of Theralase Technologies Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Theralase Technologies Inc.’s P/E ratio is -11.44.
What is the Price-to-Book ratio of Theralase Technologies Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Theralase Technologies Inc. P/B ratio is 38.7534.
What is the 50-day moving average of Theralase Technologies Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Theralase Technologies Inc. 50-day moving average is $0.1474.
